Long-term albendazole treatment should be given to all patients with unresectable hepatic alveolar echinococcosis as dramatic regression is possible in 15%-20%. It may be prudent to prepare a living donor for possible salvage transplant in case of a severe complication. Preemptive transplantation in mildly symptomatic patients should be discouraged.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380084 | PMC |
| http://dx.doi.org/10.1002/ccr3.4666 | DOI Listing |
Publication Analysis
Top Keywords
unresectable hepatic
8
hepatic alveolar
8
dramatic response
4
response albendazole
4
albendazole transplantation
4
transplantation candidates
4
candidates unresectable
4
alveolar hydatid
4
hydatid disease
4
disease long-term
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!